Gamma-glutamyltransferase, possible novel biomarker in colon diverticulosis: a case-control study

12Citations
Citations of this article
11Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

The gamma-glutamyltransferase (GGT) is recognized in medical practice as a useful indicator for the detection of liver lesions, especially those induced by the excessive consumption of alcoholic or cholesterol-associated drinks. The present study, although it includes a very small number of cases diagnosed with colon diverticulosis-diverticulitis associated with polyposis at the same intestinal level, identifies the presence of increased circulating concentrations of this enzyme in the serum. Its serum levels are tracked “dynamically” throughout a year after the diagnosis and start of the therapy. The study calls into question the release of the enzyme from the edge of the enterocytes’ brush-like edge, leading to the pathogenic disturbance of regional redox homeostasis. The hypothesis gives the circulating values of GGT predictive value for cellular oxidative stress, as well as for indirectly expressing the glutathione level in cytosol.

Cite

CITATION STYLE

APA

Bălăeţ, C., Coculescu, B. I., Manole, G., Bălăeţ, M., & Dincă, G. V. (2018). Gamma-glutamyltransferase, possible novel biomarker in colon diverticulosis: a case-control study. Journal of Enzyme Inhibition and Medicinal Chemistry, 33(1), 428–432. https://doi.org/10.1080/14756366.2018.1428802

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free